Bahnson Tristram D, Eyerly Stephanie A, Hollender Peter J, Doherty Joshua R, Kim Young-Joong, Trahey Gregg E, Wolf Patrick D
Duke Center for Atrial Fibrillation, Duke University Medical Center, North Carolina, USA; Division of Cardiovascular Medicine, Cardiac Electrophysiology Section, Duke University, North Carolina, USA.
J Cardiovasc Electrophysiol. 2014 Dec;25(12):1275-83. doi: 10.1111/jce.12514. Epub 2014 Sep 10.
Visual confirmation of radiofrequency ablation (RFA) lesions during clinical cardiac ablation procedures could improve procedure efficacy, safety, and efficiency. It was previously shown that acoustic radiation force impulse (ARFI) imaging can identify RFA lesions in vitro and in vivo in an animal model. This is the "first-in-human" feasibility demonstration of intracardiac ARFI imaging of RFA lesions in patients undergoing catheter ablation for atrial flutter (AFL) or atrial fibrillation (AF).
Patients scheduled for right atrial (RA) ablation for AFL or left atrial (LA) ablation for drug refractory AF were eligible for imaging. Diastole-gated intracardiac ARFI images were acquired using one of two equipment configurations: (1) a Siemens ACUSON S2000™ ultrasound scanner and 8/10Fr AcuNav™ ultrasound catheter, or (2) a CARTO 3™ integrated Siemens SC2000™ and 10Fr SoundStar™ ultrasound catheter. A total of 11 patients (AFL = 3; AF = 8) were imaged. ARFI images were acquired of ablation target regions, including the RA cavotricuspid isthmus (CTI), and the LA roof, pulmonary vein ostia, posterior wall, posterior mitral valve annulus, and the ridge between the pulmonary vein and LA appendage. ARFI images revealed increased relative myocardial stiffness at ablation catheter contact sites after RFA and at anatomical mapping-tagged RFA treatment sites.
ARFI images from a pilot group of patients undergoing catheter ablation for AFL and AF demonstrate the ability of this technique to identify intra-procedure RFA lesion formation. The results encourage further refinement of ARFI imaging clinical tools and continued investigation in larger clinical trials.
在临床心脏消融手术中,对射频消融(RFA)损伤进行视觉确认可提高手术的有效性、安全性和效率。先前的研究表明,声辐射力脉冲(ARFI)成像能够在动物模型的体外和体内识别RFA损伤。这是对接受导管消融治疗心房扑动(AFL)或心房颤动(AF)的患者进行心脏内ARFI成像RFA损伤的“首例人体”可行性论证。
计划接受右心房(RA)消融治疗AFL或左心房(LA)消融治疗药物难治性AF的患者符合成像条件。使用以下两种设备配置之一采集舒张期门控心脏内ARFI图像:(1)西门子ACUSON S2000™超声扫描仪和8/10Fr AcuNav™超声导管,或(2)CARTO 3™集成西门子SC2000™和10Fr SoundStar™超声导管。共有11例患者(AFL = 3;AF = 8)接受了成像。采集了消融目标区域的ARFI图像,包括RA腔静脉三尖瓣峡部(CTI)以及LA顶部、肺静脉开口、后壁、二尖瓣后瓣环,以及肺静脉与LA附件之间嵴的图像。ARFI图像显示,RFA后消融导管接触部位以及解剖标测标记的RFA治疗部位的心肌相对硬度增加。
来自接受AFL和AF导管消融治疗的试验组患者的ARFI图像证明了该技术识别术中RFA损伤形成的能力。这些结果鼓励进一步完善ARFI成像临床工具,并在更大规模的临床试验中继续开展研究。